Obroncology Video indir

Ivo Abraham, Phd, Rn, Explains The Key Features Of A Biosimilar
1:11
417
OBRoncology
Ivo Abraham, Phd, Rn, Explains The Key Features Of A Biosimilar
7 yıl önce
Ivo Abraham, Phd, Rn, Discusses Those Biosimilars That Are Approved Or Close To Approval
1:01
131
OBRoncology
Ivo Abraham, Phd, Rn, Discusses Those Biosimilars That Are Approved Or Close To...
7 yıl önce
Ivo Abraham, Phd, Rn, Speculates On The Hurdles That Could Prevent The Adoption Of Biosimilars
2:42
148
OBRoncology
Ivo Abraham, Phd, Rn, Speculates On The Hurdles That Could Prevent The Adoption...
7 yıl önce
Mary Kruczynski Tells Us How The Cost Drivers In Cancer Care Study Was Developed
0:53
5
OBRoncology
Mary Kruczynski Tells Us How The Cost Drivers In Cancer Care Study Was Developed
9 yıl önce
Ivo Abraham, Phd, Rn, Comments On How We Can Demonstrate The Value Of Cancer Treatments
1:55
334
OBRoncology
Ivo Abraham, Phd, Rn, Comments On How We Can Demonstrate The Value Of Cancer...
7 yıl önce
Lee Schwartzberg, Md, On Whether Clinical Trial Experience With I-O Translates To Routine Care
1:23
19
OBRoncology
Lee Schwartzberg, Md, On Whether Clinical Trial Experience With I-O Translates...
5 yıl önce
Jeannie Brant, Phd, Aprn, Aocn, Faan, On The Role Of A Medical Home And Palliative Care
1:30
5
OBRoncology
Jeannie Brant, Phd, Aprn, Aocn, Faan, On The Role Of A Medical Home And...
8 yıl önce
Christopher Logothetis, Md, Speculates On The Cost Implications Of Abiraterone
0:36
41
OBRoncology
Christopher Logothetis, Md, Speculates On The Cost Implications Of Abiraterone
8 yıl önce
William K. Oh, Md, Offers Opinion On The Role Of Chemotherapy In The Treatment Of Mcrpc
1:25
17
OBRoncology
William K. Oh, Md, Offers Opinion On The Role Of Chemotherapy In The Treatment...
4 yıl önce
Robert J. Brooks, Md, Offers Advantages And Disadvantages Of Joining A Large Oncology Group
1:05
58
OBRoncology
Robert J. Brooks, Md, Offers Advantages And Disadvantages Of Joining A Large...
5 yıl önce
Sibel Blau, Md, Tells Us More About Iq Oncology
1:15
22
OBRoncology
Sibel Blau, Md, Tells Us More About Iq Oncology
6 yıl önce
Edith P. Mitchell, Md, Explains How Organoids Are Being Used For Cancer Biology Research
0:52
35
OBRoncology
Edith P. Mitchell, Md, Explains How Organoids Are Being Used For Cancer Biology...
8 yıl önce
Michael Diaz, Md, On How Community Oncology Is Shaping The Future Of Cancer Care
1:06
17
OBRoncology
Michael Diaz, Md, On How Community Oncology Is Shaping The Future Of Cancer Care
6 yıl önce
Christopher Logothetis, Md, Offers Opinion On The Efficacy Of The Ar-V7 Test
0:28
74
OBRoncology
Christopher Logothetis, Md, Offers Opinion On The Efficacy Of The Ar-V7 Test
8 yıl önce
Derek Raghavan, Md, Provides A General Overview Of Prostate Cancer Therapies
2:48
56
OBRoncology
Derek Raghavan, Md, Provides A General Overview Of Prostate Cancer Therapies
5 yıl önce
Obr Summer News Flash
1:02
80
OBRoncology
Obr Summer News Flash
8 yıl önce
Sibel Blau, Md, Shares What The Qccan Is Doing For Participating Members
2:32
23
OBRoncology
Sibel Blau, Md, Shares What The Qccan Is Doing For Participating Members
6 yıl önce
Suanne Gersdorf, Fache, Msb, Shares How 340B Has Impacted Her Practice
1:49
32
OBRoncology
Suanne Gersdorf, Fache, Msb, Shares How 340B Has Impacted Her Practice
7 yıl önce
Stephen Grubbs, Md, Discusses How We Measure Quality Cancer Care Today
0:45
3
OBRoncology
Stephen Grubbs, Md, Discusses How We Measure Quality Cancer Care Today
7 yıl önce
Steven Damato, Bspharm, Describes Best Practices And New Programs Being Adopted To Treat Patients
1:29
10
OBRoncology
Steven Damato, Bspharm, Describes Best Practices And New Programs Being Adopted...
5 yıl önce
David Eagle, Md, Enumerates What Oncologists Can Do To Bring Cancer Costs Down
0:26
16
OBRoncology
David Eagle, Md, Enumerates What Oncologists Can Do To Bring Cancer Costs Down
9 yıl önce
Peter C. Black, Md, Facs, Frcsc, On The Usefulness Of Molecular Markers In Bladder Cancer Treatment
1:45
22
OBRoncology
Peter C. Black, Md, Facs, Frcsc, On The Usefulness Of Molecular Markers In...
7 yıl önce
Jennie Crews, Md, Mmm, Facp, On Embracing New Value-Based Oncology Models
0:32
30
OBRoncology
Jennie Crews, Md, Mmm, Facp, On Embracing New Value-Based Oncology Models
7 yıl önce
William Harwin, Md, Explains How He Manages The Quality Measures Required For Ocm
0:42
51
OBRoncology
William Harwin, Md, Explains How He Manages The Quality Measures Required For...
8 yıl önce
Jennie Crews, Md, Mmm, Facp, Explains How To Maintain The Delivery Of Quality Cancer Care
0:36
20
OBRoncology
Jennie Crews, Md, Mmm, Facp, Explains How To Maintain The Delivery Of Quality...
7 yıl önce
David Roberge, Md, Explains Rationale For The Design Of The Ce.7 Trial
1:28
40
OBRoncology
David Roberge, Md, Explains Rationale For The Design Of The Ce.7 Trial
5 yıl önce
Edward Kim, Md, Provides Insight On How To Use The Pd-L1 Biomarker To Direct Therapy
0:38
9
OBRoncology
Edward Kim, Md, Provides Insight On How To Use The Pd-L1 Biomarker To Direct...
8 yıl önce
Naiyer Rizvi, Md, Offers Thoughts On The Role Of Blood Tmb Vs. Tissue Tmb
1:55
43
OBRoncology
Naiyer Rizvi, Md, Offers Thoughts On The Role Of Blood Tmb Vs. Tissue Tmb
6 yıl önce
Lisa Rometty Explains How Augmented Intelligence Is Helping Oncologists Better Treat Cancer Patients
0:51
114
OBRoncology
Lisa Rometty Explains How Augmented Intelligence Is Helping Oncologists Better...
7 yıl önce
Harry Mac Barnes, Md, Explains The Benefits Of Training Advanced Practitioners
0:54
146
OBRoncology
Harry Mac Barnes, Md, Explains The Benefits Of Training Advanced Practitioners
7 yıl önce
Deborah Shrag, Md, Mph, On Which Biomarkers Are Important In The Diagnosis Management Of Crc
2:03
10
OBRoncology
Deborah Shrag, Md, Mph, On Which Biomarkers Are Important In The Diagnosis...
6 yıl önce
Jamie Bachman, Mpa, On The Potential Drawbacks Associated With Oncology-Specific Ehrs
0:39
44
OBRoncology
Jamie Bachman, Mpa, On The Potential Drawbacks Associated With...
7 yıl önce
Kim N. Chi, Md, Considers The Impact Of The Crossover Design In The Analysis Of The Titan Study
1:04
15
OBRoncology
Kim N. Chi, Md, Considers The Impact Of The Crossover Design In The Analysis Of...
4 yıl önce
Eric Jonasch, Md, On Integrating Immunotherapies Into Renal Cell Carcinoma Treatment Algorithms
0:27
51
OBRoncology
Eric Jonasch, Md, On Integrating Immunotherapies Into Renal Cell Carcinoma...
8 yıl önce
William Oh, Md, Considers The Role Of Biomarker Selection Trials In Prostate Cancer
1:09
10
OBRoncology
William Oh, Md, Considers The Role Of Biomarker Selection Trials In Prostate...
6 yıl önce
© 2025 VideoindirXa.Net by NEMO